PF-06747143, a humanized anti-CXCR4 immunoglobulin G1 (IgG1) antibody, is used to fight hematological malignancies and also inhibit downstream pathways activated by the CXCL12/CXCR4 axis. Here, CXCR4 is linked to hematologic disorder.